Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Guillem Argilés(Vall d'Hebron Hospital Universitari), Dirk Arnold(Asklepios Klinik Altona), Ramón Salazar(Institut Català d'Oncologia), Timothy Iveson(University Hospital Southampton NHS Foundation Trust), Philip Quirke(University of Leeds), Takayuki Yoshino(University of Tsukuba), Erika Martinelli(University of Campania "Luigi Vanvitelli"), Roberto Labianca(Ospedale Papa Giovanni XXIII), Daniel Hochhauser(Royal London Hospital), Josep Tabernero(Deaconess Hospital), Pierre Laurent‐Puig(Inserm), Julien Taı̈eb(Hôpital Européen Georges-Pompidou)
Cited by 1,317
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k